AbbVie, FTC Tussle Over High Court's View On Disgorgement
AbbVie and the Federal Trade Commission are both pointing to a U.S. Supreme Court decision this week on securities fraud to boost their arguments in the Third Circuit over a $448...To view the full article, register now.
Already a subscriber? Click here to view full article